Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesValidation of the Pedigree Assessment Tool (PAT) in Families with BRCA1 and BRCA2 Mutations
Annals of Surgical Oncology, 09/21/09
Teller P et al. – In overall performance, the PAT is at least comparable to the Myriad II and Penn II models in screening women appropriate for genetic referral. Simplicity and identification of families with non–BRCA hereditary BC syndromes suggest that the PAT is better suited for BC risk screening.
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 70%
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers
Breast Cancer Research, 10/26/09
Relevance Score: 70%
The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers
Breast Cancer Research and Treatment, 11/04/09
Relevance Score: 69%
Identification and comprehensive characterization of large genomic rearrangements in the BRCA1 and BRCA2 genes
Breast Cancer Research and Treatment, 11/13/09
Relevance Score: 67%
Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin
Oncogene, 10/14/09
Relevance Score: 67%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo
The American Journal of Surgery, 12/11/09
Nipple adenoma in infancy
Journal of Pediatric Surgery, 12/11/09
Private insurance is the strongest predictor of women receiving breast conservation surgery for breast cancer
The American Journal of Surgery, 12/11/09
Today in Surgical Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Malignant tumor of the trachea in children: diagnostic pitfalls and surgical management
Journal of Pediatric Surgery, 12/13/09
Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer
Clinical Cancer Research, 12/11/09
An Update on Laparoscopic Resection for Rectal Cancer
Cancer Control, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor